Amy Klobuchar actually said...

allows operating companies to exploit the lack of transparency in patent ownership to win a tactical advantage that could not be gained with...

We are also a strong supporter of another bipartisan bill, Senate bill 504, the Fair and Immediate Release of Generics Act.

Hatch-Waxman is supposed to be about--at least paragraph 4 certifications--challenging invalid or not infringed patents.

we need this to have the Justice Department function.